The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A window-of-opportunity (WOO) trial of giredestrant +/- LHRHa vs anastrozole+LHRHa in premenopausal women with ER+/HER2- early breast cancer (EBC; IBCSG 67-22; PREcoopERA).
 
Elisabetta Munzone
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Exact Sciences; Ipsen; MSD Oncology; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
 
Ruichao Shi
No Relationships to Disclose
 
Sherene Loi
Honoraria - Mersana; MSD Oncology; Novartis; Roche/Genentech
Consulting or Advisory Role - Aduro Biotech (Inst); AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Lilly (Inst); G1 Therapeutics (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst); Silverback Therapeutics (Inst); Tallac Therapeutics (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - BMS
Other Relationship - Roche Medical writing support
 
Marco Colleoni
Research Funding - Roche (Inst)
 
Giuseppe Viale
Honoraria - Daiichi Sankyo Europe GmbH; Gilead/Forty Seven
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Dako; Menarini; MSD Oncology; Novartis; Roche/Genentech
Research Funding - AstraZeneca (Inst); Cepheid (Inst); Dako/Agilent Technologies (Inst); Roche/Genentech (Inst); Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH
 
Vesna Bjelic-Radisic
Speakers' Bureau - Lilly (Inst)
 
Antonia Perello
No Relationships to Disclose
 
Per Karlsson
Speakers' Bureau - AstraZeneca; Novartis; Seagen
Patents, Royalties, Other Intellectual Property - Contract with Prelude DX regarding biomarkers for radiation sensitivity; Pending application of patent for a RT biomarker; Research contract with PFS genomics (aquired by Exact Sciences 2021)regarding gene profiling and intelectual property/royalties; Research contract with PFS genomics regarding gene profiling and intelectual property/royalties
 
Balazs Madaras
No Relationships to Disclose
 
Roisin M. Connolly
Consulting or Advisory Role - Astra Zeneca/Daichii; AstraZeneca; Gilead Sciences
Research Funding - AstraZeneca (Inst); Daichii Sankyo (Inst); MSD (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis Ireland Ltd.
Other Relationship - Roche
(OPTIONAL) Uncompensated Relationships - AICRI; Astra Zeneca/Daichii (HER2 low obs study); Decrescendo; Develop Med; Seagen
 
Joana M. Ribeiro
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; MSD
Speakers' Bureau - Gilead Sciences; MSD
Travel, Accommodations, Expenses - Gilead Sciences; MSD; Novartis; Roche
 
Heidi Roschitzki-Voser
No Relationships to Disclose
 
Roswitha Kammler
No Relationships to Disclose
 
Barbara Ruepp
No Relationships to Disclose
 
Meredith M. Regan
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Tersera; Tolmar
Research Funding - AstraZeneca (Inst); Bayer (Inst); bioTheranostics (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); TerSera (Inst)
 
Peter Christian Dubsky
Consulting or Advisory Role - AstraZeneca (Inst); Roche/Genentech (Inst)
Research Funding - Cepheid/Danaher (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca (Inst); Roche (Inst)